Literature DB >> 25056896

Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.

Danyang Gong1, Nicholas C Wu1, Yafang Xie1, Jun Feng1, Leming Tong1, Kevin F Brulois2, Harding Luan1, Yushen Du1, Jae U Jung2, Cun-yu Wang3, Mo Kwan Kang3, No-Hee Park4, Ren Sun5, Ting-Ting Wu5.   

Abstract

UNLABELLED: Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with several human malignances. As saliva is likely the major vehicle for KSHV transmission, we studied in vitro KSHV infection of oral epithelial cells. Through infection of two types of oral epithelial cells, normal human oral keratinocytes (NHOKs) and papilloma-immortalized human oral keratinocyte (HOK16B) cells, we found that KSHV can undergo robust lytic replication in oral epithelial cells. By employing de novo lytic infection of HOK16B cells, we studied the functions of two previously uncharacterized genes, ORF18 and ORF30, during the KSHV lytic cycle. For this purpose, an ORF18-deficient virus and an ORF30-deficient virus were generated using a mutagenesis strategy based on bacterial artificial chromosome (BAC) technology. We found that neither ORF18 nor ORF30 is required for immediately early or early gene expression or viral DNA replication, but each is essential for late gene expression during both de novo lytic replication and reactivation. This critical role of ORF18 and ORF30 in late gene expression was also observed during KSHV reactivation. In addition, global analysis of viral transcripts by RNA sequencing indicated that ORF18 and ORF30 control the same set of viral genes. Therefore, we suggest that these two viral ORFs are involved in the same mechanism or pathway that coregulates the viral late genes as a group. IMPORTANCE: While KSHV can infect multiple cell types in vitro, only a few can support a full lytic replication cycle with progeny virions produced. Consequently, KSHV lytic replication is mostly studied through reactivation, which requires chemicals to induce the lytic cycle or overexpression of the viral transcriptional activator, RTA. In this study, we present a robust de novo lytic infection system based on oral epithelial cells. Using this system, we demonstrate the role of two viral ORFs, ORF18 and ORF30, in regulating viral gene expression during KSHV lytic replication. As the major route of KSHV transmission is thought to be via saliva, this new KSHV lytic replication system will have important utility in the field.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056896      PMCID: PMC4178812          DOI: 10.1128/JVI.00793-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates.

Authors:  D M Koelle; M L Huang; B Chandran; J Vieira; M Piepkorn; L Corey
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

2.  A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle.

Authors:  T R Serio; N Cahill; M E Prout; G Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus.

Authors:  I Boldogh; P Szaniszlo; W A Bresnahan; C M Flaitz; M C Nichols; T Albrecht
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

4.  The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease).

Authors:  M Corbellino; L Poirel; J T Aubin; M Paulli; U Magrini; G Bestetti; M Galli; C Parravicini
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

5.  The restricted cellular host range of human herpesvirus 8.

Authors:  D J Blackbourn; E Lennette; B Klencke; A Moses; B Chandran; M Weinstein; R G Glogau; M H Witte; D L Way; T Kutzkey; B Herndier; J A Levy
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

6.  Mucosal shedding of human herpesvirus 8 in men.

Authors:  J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

7.  Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma.

Authors:  J Vieira; M L Huang; D M Koelle; L Corey
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

9.  KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.

Authors:  S J Gao; C Boshoff; S Jayachandra; R A Weiss; Y Chang; P S Moore
Journal:  Oncogene       Date:  1997-10-16       Impact factor: 9.867

10.  Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model.

Authors:  N H Park; C N Gujuluva; J H Baek; H M Cherrick; K H Shin; B M Min
Journal:  Oncogene       Date:  1995-06-01       Impact factor: 9.867

View more
  27 in total

1.  ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Xiaojuan Li; Shumin Du; Denis Avey; Yuqing Li; Fanxiu Zhu; Ersheng Kuang
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  CryoEM and mutagenesis reveal that the smallest capsid protein cements and stabilizes Kaposi's sarcoma-associated herpesvirus capsid.

Authors:  Xinghong Dai; Danyang Gong; Yuchen Xiao; Ting-Ting Wu; Ren Sun; Z Hong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells.

Authors:  A Gregory Bruce; Serge Barcy; Terri DiMaio; Emilia Gan; H Jacques Garrigues; Michael Lagunoff; Timothy M Rose
Journal:  Pathogens       Date:  2017-03-19

4.  Association of Kaposi's Sarcoma-Associated Herpesvirus ORF31 with ORF34 and ORF24 Is Critical for Late Gene Expression.

Authors:  Kevin Brulois; Lai-Yee Wong; Hye-Ra Lee; Priyanka Sivadas; Armin Ensser; Pinghui Feng; Shou-Jiang Gao; Zsolt Toth; Jae U Jung
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

5.  Kaposi's Sarcoma-Associated Herpesvirus ORF66 Is Essential for Late Gene Expression and Virus Production via Interaction with ORF34.

Authors:  Tadashi Watanabe; Mayu Nishimura; Taisuke Izumi; Kazushi Kuriyama; Yuki Iwaisako; Kohei Hosokawa; Akifumi Takaori-Kondo; Masahiro Fujimuro
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

6.  Conserved CxnC Motifs in Kaposi's Sarcoma-Associated Herpesvirus ORF66 Are Required for Viral Late Gene Expression and Are Essential for Its Interaction with ORF34.

Authors:  Allison L Didychuk; Angelica F Castañeda; Lola O Kushnir; Carolyn J Huang; Britt A Glaunsinger
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

7.  A Herpesvirus Protein Selectively Inhibits Cellular mRNA Nuclear Export.

Authors:  Danyang Gong; Yong Hoon Kim; Yuchen Xiao; Yushen Du; Yafang Xie; Kevin K Lee; Jun Feng; Nisar Farhat; Dawei Zhao; Sara Shu; Xinghong Dai; Sumit K Chanda; Tariq M Rana; Nevan J Krogan; Ren Sun; Ting-Ting Wu
Journal:  Cell Host Microbe       Date:  2016-11-09       Impact factor: 21.023

8.  Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.

Authors:  Danyang Gong; Xinghong Dai; Yuchen Xiao; Yushen Du; Travis J Chapa; Jeffrey R Johnson; Xinmin Li; Nevan J Krogan; Hongyu Deng; Ting-Ting Wu; Ren Sun
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 9.  An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle.

Authors:  Adityarup Chakravorty; Bill Sugden; Eric C Johannsen
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 10.  Hijacking GPCRs by viral pathogens and tumor.

Authors:  Junjie Zhang; Hao Feng; Simin Xu; Pinghui Feng
Journal:  Biochem Pharmacol       Date:  2016-04-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.